Annual report pursuant to Section 13 and 15(d)

Cover

v3.23.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Mar. 17, 2023
Jun. 30, 2022
Cover [Abstract]        
Document Type 10-K      
Amendment Flag false      
Document Annual Report true      
Document Transition Report false      
Document Period End Date Dec. 31, 2022      
Document Fiscal Period Focus FY      
Document Fiscal Year Focus 2022      
Current Fiscal Year End Date --12-31      
Entity File Number 000-24249      
Entity Registrant Name Interpace Biosciences, Inc.      
Entity Central Index Key 0001054102      
Entity Tax Identification Number 22-2919486      
Entity Incorporation, State or Country Code DE      
Entity Address, Address Line One Morris Corporate Center 1      
Entity Address, Address Line Two Building C      
Entity Address, Address Line Three 300 Interpace Parkway      
Entity Address, City or Town Parsippany      
Entity Address, State or Province NJ      
Entity Address, Postal Zip Code 07054      
City Area Code 855      
Local Phone Number 776-6419      
Entity Well-known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company false      
Entity Shell Company false      
Entity Public Float       $ 11,565,729
Entity Common Stock, Shares Outstanding     4,311,414  
Documents Incorporated by Reference [Text Block] Part III of this Annual Report on Form 10-K will be incorporated by reference from certain portions of the Registrant’s definitive proxy statement for the 2023 annual meeting of stockholders, or Proxy Statement, or will be included in an amendment hereto, to be filed within 120 days of the end of the fiscal year ended December 31, 2022. Except with respect to information specifically incorporated by reference in this Annual Report on Form 10-K, the Proxy Statement is not deemed to be filed as part hereof      
ICFR Auditor Attestation Flag false      
Auditor Firm ID 274 243    
Auditor Name EISNERAMPER LLP BDO USA, LLP    
Auditor Location Philadelphia, Pennsylvania Woodbridge, NJ